Characterization of a recurrent t(1;2)(p36;p24) in human uterine leiomyoma.

[1]  D. Moras,et al.  Monitoring ligand modulation of protein-protein interactions by mass spectrometry: estrogen receptor alpha-SRC1. , 2008, Analytical chemistry.

[2]  J. Oberyé,et al.  Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix , 2005, BJOG : an international journal of obstetrics and gynaecology.

[3]  M. Tang,et al.  Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. , 2005, Human reproduction.

[4]  A. Sandberg.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma. , 2005, Cancer genetics and cytogenetics.

[5]  G. de Rosa,et al.  Clinical Response, Vascular Change, and Angiogenesis in Gonadotropin-Releasing Hormone Analogue-Treated Women with Uterine Myomas , 2005, The Journal of the Society for Gynecologic Investigation: JSGI.

[6]  P. Cin,et al.  Uterine Leiomyomata with t(10;17) Disrupt the Histone Acetyltransferase MORF , 2004, Cancer Research.

[7]  M. Payson,et al.  Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids , 2004, Genes, chromosomes & cancer.

[8]  N. Matsumura,et al.  PEP-19 overexpression in human uterine leiomyoma. , 2003, Molecular human reproduction.

[9]  B. Vollenhoven,et al.  Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. , 2003, Molecular human reproduction.

[10]  G. Stein,et al.  Tumor suppressor pRB functions as a co‐repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription , 2003, Journal of cellular physiology.

[11]  J. Warrington,et al.  Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. , 2003, Fertility and sterility.

[12]  J. Segars,et al.  Microarray analysis in fibroids: which gene list is the correct list? , 2003, Fertility and sterility.

[13]  D. Dixon,et al.  Etiology and pathogenesis of uterine leiomyomas: a review. , 2003, Environmental health perspectives.

[14]  G. Merkx,et al.  Pathogenesis of axonal dystrophy and demyelination in αA‐crystallin‐expressing transgenic mice , 2003, International journal of experimental pathology.

[15]  R. Williams,et al.  Gene Expression Profile of Leiomyoma and Myometrium and the Effect of Gonadotropin Releasing Hormone Analogue Therapy , 2003, The Journal of the Society for Gynecologic Investigation: JSGI.

[16]  V. Giguère,et al.  Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. , 2003, Molecular endocrinology.

[17]  B. O’Malley,et al.  Molecular Mechanisms and Cellular Biology of the Steroid Receptor Coactivator (SRC) Family in Steroid Receptor Function , 2002, Reviews in Endocrine and Metabolic Disorders.

[18]  S. Mane,et al.  Insights from gene arrays on the development and growth regulation of uterine leiomyomata. , 2002, Fertility and sterility.

[19]  Y. Barrandon,et al.  The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle. , 2001, Genes & development.

[20]  C. Turck,et al.  Growth Factors Signal to Steroid Receptors through Mitogen-activated Protein Kinase Regulation of p160 Coactivator Activity* , 2001, The Journal of Biological Chemistry.

[21]  B. S. Lee,et al.  Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  N. Bajekal,et al.  Fibroids, infertility and pregnancy wastage. , 2000, Human reproduction update.

[23]  B. Kay,et al.  Intersectin, an adaptor protein involved in clathrin-mediated endocytosis, activates mitogenic signaling pathways. , 2000, The Journal of biological chemistry.

[24]  J. Font de Mora,et al.  AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[25]  R. Schiltz,et al.  Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Cin,et al.  HMGI-C and HMGI(Y) Immunoreactivity Correlates with Cytogenetic Abnormalities in Lipomas, Pulmonary Chondroid Hamartomas, Endometrial Polyps, and Uterine Leiomyomas and is Compatible with Rearrangement of the HMGI-C and HMGI(Y) Genes , 2000, Laboratory Investigation.

[27]  Stephen A. Krawetz,et al.  Bioinformatics Methods and Protocols , 1999 .

[28]  E. Outwater,et al.  Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[29]  E. Schoenmakers,et al.  Deletion 7q in uterine leiomyoma: fluorescence in situ hybridization characterization on primary cytogenetic preparations. , 1999, Cancer genetics and cytogenetics.

[30]  A. Nepveu,et al.  The mammalian Cut homeodomain protein functions as a cell‐cycle‐dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase , 1998, The EMBO journal.

[31]  C. Morton,et al.  The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. , 1997, Cancer genetics and cytogenetics.

[32]  C. Allis,et al.  Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.

[33]  U. Surti,et al.  Two discrete regions of deletion at 7q in uterine leiomyomas , 1997, Genes, chromosomes & cancer.

[34]  S. Scherer,et al.  Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas , 1997, Oncogene.

[35]  J. Bullerdiek,et al.  PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line , 1996 .

[36]  Herman Van den Berghe,et al.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours , 1995, Nature Genetics.

[37]  J. Fletcher,et al.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains , 1995, Cell.

[38]  D. Weghuis,et al.  Amplification of chromosome subregion 12p11.2-p12.1 in a metastasis of an i(12p)-negative seminoma: relationship to tumor progression? , 1994, Cancer genetics and cytogenetics.

[39]  J. Bullerdiek,et al.  Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas , 1994, Genes, chromosomes & cancer.

[40]  U. Surti,et al.  Deletion 7q22 in uterine leiomyoma. A cytogenetic review. , 1993, Cancer genetics and cytogenetics.

[41]  W. Vale,et al.  Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist * † , 1993 .

[42]  A. Patel,et al.  The frequency of uterine leiomyomas. , 1990, American journal of clinical pathology.

[43]  P. Cin,et al.  Is the chromosome band 1p36 another hot‐spot for rearrangements in uterine leiomyoma? , 1990, Genes, chromosomes & cancer.

[44]  B. Vollenhoven,et al.  Uterine fibroids: A clinical review , 1990, British journal of obstetrics and gynaecology.

[45]  J. Mark,et al.  Cytogenetical observations in human benign uterine leiomyomas. , 1988, Anticancer research.

[46]  A. Hagemeijer,et al.  Expression of human myeloid-associated surface antigens in human-mouse myeloid cell hybrids. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[48]  W. V. D. Van de Ven,et al.  Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. , 1999, Cancer research.

[49]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.